2012-06-24から1日間の記事一覧
Sorafenib which is known as Nexavar is pan-RTK inhibitor and molecular targeted drug. This is developed by Bayer and Onyx Pharmaceuticals, and FDA has approved it to treat hepatocellular carcinoma and renal carcinoma. In Japan, this drug h…